Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa

Universidad de Granada30 enrolled

Overview

The aim of this study is to evaluate the efficacy of cognitive - behavioral therapy for the control of psychopathological stress and the disease of people with Retinitis Pigmentosa (RP).

This randomized controlled trial aims to evaluate the efficacy of cognitive - behavioral therapy for the control of psychopathological stress and the disease of people with Retinitis Pigmentosa (RP) on aspects such as vulnerability to stress, perceived stress, psychopathological state, general self-efficacy, resilience, satisfaction with social support and visual field. This study has two groups: 1) cognitive - behavioral therapy group, and 2) Standard intervention or control group. The two interventions will be conducted for 3 months (with a total of 12 sessions), one session per week, with a duration of 90 minutes per session.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Vision Disorders Stress, Psychological Psychopathy Self Efficacy

Interventions

A cognitive-behavioral intervention programBEHAVIORAL

In this program, participants receive a training of assertive skills, social skills, acceptance, among other psychological aspects.

Standard interventionOTHER

Participants receive different activities conducted by a psychologist in the association where the attend.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosed with Retinitis Pigmentosa (legally blind RP patients). * meet the membership criteria of the Spanish National Association of ONCE. * having a reduction of the visual field of at least 10 degrees in both eyes * having an age between 18 and 65 years. Exclusion Criteria: * no visual remainders (advanced retinosis). * no studies. * cognitive impairment, determined by the Spanish Mini-Mental State Examination - MMSE test. * mobility problems * high risk of falls associated with retinosis, measured by the Morse scale, with a score over 50 points.

Locations (1)

José Manuel Pérez Mármol

Granada, Spain

Outcomes

Primary Outcomes

Change from Baseline in vulnerability to stress at 12 weeks

This scale registeres the aspects that influence the ability to deal with stress

Time frame: Twelve weeks

Secondary Outcomes

Change from Baseline in Perceived stress scale at 12 weeks

This scale evaluates the degree to which situations in one's life are appraised as stressful

Time frame: Twelve weeks

Change from Baseline in Symptom Checklist-90-Revised Questionnaire at 12 weeks

This instrument is a 90-item self-report symptom inventory developed by Leonard R. Derogatis in the mid-1970s to measure psychological symptoms and psychological distress.

Time frame: Twelve weeks

Change from Baseline in General Self efficacy scale at 12 weeks

This scale assesses people's stable believe about their ability to appropriately manage a wide kind of life stressors

Time frame: Twelve weeks

Change from Baseline in Connor-Davidson Resilience Scale at 12 weeks

This scale evaluates stress coping ability.

Time frame: Twelve weeks

Change from Baseline in Social support questionnaire at 12 weeks

This instrument evaluates perceived Social support.

Time frame: Twelve weeks

Change from Baseline in Visual Field Test at 12 weeks

This method evaluates the visual field of two eyes

Time frame: Twelve weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.